16 false true https://www.consorci.org/ ORG-0001 Consorci de Salut i d’Atenció Social de Catalunya Avinguda Tibidabo 21 Barcelona 08022 ES511 ESP P0800004D +34 932531820 suppliers@suhco.eu ORG-0002 Istituto per Servizi di Ricovero e Assistenza agli Anziani (ISRAA) Borgo Giuseppe Mazzini, 48 Treviso 31100 ITH34 ITA IT00737700260 suppliers@suhco.eu https://hduhb.nhs.wales/ ORG-0003 HDUHB Hywel Dda University Health Board Corporate Offices, Ystwyth Building, Hafan Derwen, St Davids Park, Jobswell Road Camarthen SA31 3BB GBR NA suppliers@suhco.eu https://op.europa.eu ORG-0000 Publications Office of the European Union Luxembourg 2417 LU000 LUX PUBL +352 29291 ted@publications.europa.eu 00454632-2026125/20262026-07-02+02:00 2.3 eforms-sdk-1.14 db55d15b-8352-4605-b484-f35477d3f230 9b02520b-bb26-4009-84e5-038815991cf7 2026-06-30Z 15:36:31Z 01 32014L0024 cn-standard ENG https://suhco.eu body-pl health ORG-0001 ted-esen ORG-0000 ted-esen ORG-0001 CrossBorderLaw Spanish Law 9/2017 epo-procurement-document open 713054-2025 false Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO) suHCO (Systemic Sustainability Transition Solution for Health Care Organisations) is a European project funded under the Horizon Europe programme (Grant Agreement No. 101226802) and implemented through a Pre-Commercial Procurement (PCP) scheme. The project aims to support health and care organisations in their transition towards more sustainable and environmentally responsible models by fostering the development of innovative digital solutions. Through the PCP process, suHCO will procure research and development services for the creation of an AI-enabled digital platform capable of helping healthcare organisations assess their sustainability performance, identify improvement opportunities, plan and implement actions, monitor progress, and support evidence-based decision-making. The future solution is expected to integrate sustainability knowledge, regulatory requirements, standards, best practices and relevant data sources, providing users with practical guidance tailored to their organisational context. It should also support sustainable procurement processes, impact assessment, reporting activities and organisational change management. The project is driven by a Buyers Group composed of healthcare organisations from Spain, Italy and Wales. The solutions developed during the PCP will be progressively designed, prototyped and validated in real healthcare environments to ensure their relevance, usability and scalability. By bringing together healthcare providers, technology developers and sustainability experts, suHCO seeks to stimulate innovation and contribute to the sustainability objectives of European health systems. services Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed. Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors. The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement. The research and development (R&D) services will be carried out primarily within the European Union and/or in countries associated with the Horizon Europe Programme. At least 50% of the total value of the R&D activities shall take place within the EU or associated countries. Contractors must ensure that none of the contracted services is performed in countries nor by entities that are subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that none of the goods procured or used for the procurement were developed, produced or supplied in countries or by entities that are subject to such restrictive measures. This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs. Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation. This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). *The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.* 2260980 73100000 73110000 72212445 72222300 90713000 90714100 90711300 80500000 79342200 90711000 72212783 Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy) Barcelona 08022 ES511 ESP Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy) Camarthen GBR Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy) Treviso ITH34 ITA LOT-0001 eu-funds unused-id ORG-0001 n/a non-restricted-document https://contractaciopublica.cat/en/detall-publicacio/d207dc01-f72c-4f5f-8599-cf286cac7f1c/300682768 epo-procurement-document none no required not-allowed quality Available in the tender documents https://contractaciopublica.cat/en/detall-publicacio/d207dc01-f72c-4f5f-8599-cf286cac7f1c/300682768 6 ORG-0002 ORG-0001 ORG-0003 ENG false true required false 2026-10-09+02:00 14:00:00+02:00 false fa-wo-rc none Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO) Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed. Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors. The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement. This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement. services true 2260980 73100000 Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). ES511 ESP Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). ITH34 ITA Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). GBR 2026-12-01+01:00 2028-11-30+01:00